Suppr超能文献

甘精胰岛素晚间给药与清晨给药在 2 型糖尿病患者中的药代动力学和药效学比较。

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.

机构信息

Department of Medicine, University of Perugia Medical School, Perugia, Italy.

Department of Medicine, University of Perugia Medical School, Perugia, Italy

出版信息

Diabetes Care. 2015 Mar;38(3):503-12. doi: 10.2337/dc14-0649. Epub 2014 Dec 18.

Abstract

OBJECTIVE

To compare pharmacokinetics (PK) and pharmacodynamics (PD) of insulin glargine in type 2 diabetes mellitus (T2DM) after evening versus morning administration.

RESEARCH DESIGN AND METHODS

Ten T2DM insulin-treated persons were studied during 24-h euglycemic glucose clamp, after glargine injection (0.4 units/kg s.c.), either in the evening (2200 h) or the morning (1000 h).

RESULTS

The 24-h glucose infusion rate area under the curve (AUC0-24h) was similar in the evening and morning studies (1,058 ± 571 and 995 ± 691 mg/kg × 24 h, P = 0.503), but the first 12 h (AUC0-12h) was lower with evening versus morning glargine (357 ± 244 vs. 593 ± 374 mg/kg × 12 h, P = 0.004), whereas the opposite occurred for the second 12 h (AUC12-24h 700 ± 396 vs. 403 ± 343 mg/kg × 24 h, P = 0.002). The glucose infusion rate differences were totally accounted for by different rates of endogenous glucose production, not utilization. Plasma insulin and C-peptide levels did not differ in evening versus morning studies. Plasma glucagon levels (AUC0-24h 1,533 ± 656 vs. 1,120 ± 344 ng/L/h, P = 0.027) and lipolysis (free fatty acid AUC0-24h 7.5 ± 1.6 vs. 8.9 ± 1.9 mmol/L/h, P = 0.005; β-OH-butyrate AUC0-24h 6.8 ± 4.7 vs. 17.0 ± 11.9 mmol/L/h, P = 0.005; glycerol, P < 0.020) were overall more suppressed after evening versus morning glargine administration.

CONCLUSIONS

The PD of insulin glargine differs depending on time of administration. With morning administration insulin activity is greater in the first 0-12 h, while with evening administration the activity is greater in the 12-24 h period following dosing. However, glargine PK and plasma C-peptide levels were similar, as well as glargine PD when analyzed by 24-h clock time independent of the time of administration. Thus, the results reflect the impact of circadian changes in insulin sensitivity in T2DM (lower in the night-early morning vs. afternoon hours) rather than glargine per se.

摘要

目的

比较 2 型糖尿病(T2DM)患者晚间和清晨给予甘精胰岛素后的药代动力学(PK)和药效学(PD)。

研究设计和方法

在 24 小时血糖钳夹期间,10 例接受胰岛素治疗的 T2DM 患者在皮下注射甘精胰岛素(0.4 单位/公斤)后,分别在晚间(2200 h)和清晨(1000 h)进行研究。

结果

晚间和清晨研究的 24 小时葡萄糖输注率 AUC0-24h 相似(1058±571 和 995±691mg/kg×24 h,P=0.503),但晚间甘精胰岛素的前 12 小时 AUC0-12h 较低(357±244 与 593±374mg/kg×12 h,P=0.004),而在随后的 12 小时内则相反(AUC12-24h 700±396 与 403±343mg/kg×24 h,P=0.002)。葡萄糖输注率的差异完全归因于内源性葡萄糖产生率的不同,而不是利用率的不同。晚间和清晨研究的血浆胰岛素和 C 肽水平没有差异。胰高血糖素水平(AUC0-24h 1533±656 与 1120±344ng/L/h,P=0.027)和脂肪分解(游离脂肪酸 AUC0-24h 7.5±1.6 与 8.9±1.9mmol/L/h,P=0.005;β-羟丁酸 AUC0-24h 6.8±4.7 与 17.0±11.9mmol/L/h,P=0.005;甘油,P<0.020)在晚间甘精胰岛素给药后总体上受到更大的抑制。

结论

甘精胰岛素的 PD 取决于给药时间。在清晨给药时,胰岛素在 0-12 小时内的活性更强,而在晚间给药时,在给药后 12-24 小时内的活性更强。然而,甘精胰岛素 PK 和血浆 C 肽水平相似,并且当根据 24 小时时钟时间而不是给药时间进行分析时,甘精胰岛素 PD 也相似。因此,这些结果反映了 T2DM 中胰岛素敏感性的昼夜变化的影响(夜间-清晨时段低于下午时段),而不是甘精胰岛素本身的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验